阿斯利康宣布25亿美元投资计划,用于在北京新建全球战略研发中心

南方财经网
21 Mar

  南方财经3月21日电,记者获悉,阿斯利康今天宣布25亿美元投资计划,在北京建立第六个全球战略研发中心,并达成多项重大研发与生产合作,以进一步推动中国生命科学事业发展。这项未来五年的投资计划是阿斯利康与北京市人民政府和北京经济技术开发区管理委员会战略合作伙伴关系的一部分,它同时还包括了公司与和铂医药、元思生肽、康泰生物三家生物科技企业达成的合作协议,以及近期宣布的珐博进中国收购协议。通过这一系列部署,阿斯利康预计在北京的员工人数将增至1700人。(21世纪经济报道)

(文章来源:南方财经网)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10